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The chromogenic cephalosporin nitrocefin (87/312) demonstrates rapid and visible instability to serum from many species. This phenomenon was distinct from serum binding, being significantly slower. Destruction of another cephalosporin, 10485 , by serum appeared to account for some anomalous results during investigation into its human pharmacokinetics. Many cephalosporins of very different structures also showed serum instability, unrelated to their degrees of serum binding as measured by plate assay. Extrapolation could not be made from one species to another with regard to either binding or instability. Small changes in the chemical structures of the 3-and 7-substituents of the cephalosporins made profound changes in their susceptibility to serum attack. The decomposition is pH dependent, occurring more slowly at acid pH, and is due to a high-molecularweight component of serum that resists boiling for several minutes. Isoelectric focusing of serum from several animal species gave various species-specific bands that decomposed nitrocefin. The inactivation of nitrocefin was not entirely parallel with that of 10485 and was inhibited by it. All other f8-lactam compounds tested also inhibited the reaction, much greater concentrations usually being necessary when the inhibitor was stable to serum. The complex that causes breakdown of the f8-lactam compounds is not necessarily the same as the one causing serum binding. It is postulated that serum may affect most other f,-lactam antibiotics in a similar way, although in most cases, this only occurs to a very slight extent.
The biniding of chemical substances of small molecular weight to serum proteins by hydrogen bonding modifies their biological activities, sometimes to a considerable extent. Binding to proteins is often considered to be disadvantageous for antibiotics; the greater the degree of binding, the more the antibacterial activity is reduced. The binding shown by clinically available antibiotics is essentially reversible, regardless of the extent to which a compound may be bound. Albumin is usually involved in this binding, and a wide variety of chemical structures are known that bind to it.
Recent work in our laboratories has shown that some penicillins and cephalosporins are bound irreversibly and destructively to serum proteins. Instability to serum has been demonstrated dramatically with the chromogenic cephalosporin nitrocefin (87/312), which rapidly turned a bright cherry red in serum solution (5) . At the same time, a new cephalosporin (10485, compound E in Table 4 ), then undergoing investigations into its human pharmacokinetics in our laboratories, gave unexpectedly poor serum levels and urinary recoveries. These observations led to examination of the stabilities of a range of cephalosporins and other ,B-lactam compounds in serum from several species, including humans.
MATERIALS AND METHODS
Cultures. The standard laboratory strains used were maintained on Oxoid nutrient agar slopes. Minimal inhibitory concentration determinations were carried out on Casitone agar; pooled human serum was added to the medium in some cases to give a final serum concentration of 5%. The cultures were inoculated with ca. 105 viable organisms and incubated for 18 h at 370C.
Microbiological assays. These were done by the large plate agar diffusion method by using either Bacillus subtilis ATCC 6633 in Glaxo Factor B medium (7) Isoelectric focusing. Undiluted serum from several species was focused on thin sheets of polyacrylamide gel containing Ampholine, pH 3.5 to 10 (3). Samples were applied near the anode as drops of liquid on the surface of the gel. Focusing was performed at 200 to 350 V for 48 h. The plates were stained by damping the surface of the gel with nitrocefin (0.5 mg/ml in 0.1 M phosphate buffer, pH 7). After 1 h, pink bands appeared on a yellow background. The plates were photographed by using Kodalith Ortho film with transmitted light and a Wratten green filter.
Spectrophotometric method for determination of rate of decomposition of nitrocefin by serum. The rate of breakdown of nitrocefin was determined by measuring the rate of increase of absorbance at 510 nm by using the Unicam SP 800 recording spectrophotometer (Pye-Unicam Ltd., Cambridge, England) with a 1-cm cell. The most convenient concentration was 10-4 M, i.e., 51.6 pg/ml. For such a solution, the maximal change in optical density observed was from 0.12 to 1.74. Human serum was used at a final dilution of 1:8 in the cell.
In the inhibition studies, the inhibiting compound was present in both the experimental and the reference cells at the same concentration; nitrocefin was in the experimental cell only, with a similar volume of buffer added to the reference cell.
Human pharmacokinetics. 
RESULTS
Unexpected human pharmacokinetics of cephalosporin 10485. When 10485 was examined in human subjects, the initial serum levels after one intramuscular injection of 1 g (Table  1 ) were very high, probably because of its very high serum binding, but then fell very rapidly. Assay problems were also encountered, which appeared to be due to instability of the compound in serum.
Microbiological assay showed that whereas 100% of the given dose of cefuroxime (2) appeared in the urine, only 44% of cephalothin and 25% of 10485 were recovered. Deacetylation, with its concurrent reduction in antibacterial activity, accounted for the poor recovery of cephalothin, and high-pressure liquid chromatography of the urine confirmed that the 3-hydroxymethyl metabolite accounted for all the missing material (4) and that therefore there had been no destruction of the basic cephalosporin structure. The missing 75% of 10485, however, could not be accounted for simply by deacetylation; 10485 was much less susceptible to mammalian esterase attack than cephalothin (Table 2) , and no desacetyl metabolite was found in the volunteers. This low recovery of 10485 by both methods of estimation suggested that it had undergone a type of decomposition in the (Table 5) showed no obvious structural associations with serum instability.
Some properties of the serum reaction with nitrocefin. These are summarized in Table 6. (i) Effect of pH on the serum reaction. The rate at which the colored decomposition product was produced in the presence of serum decreased with decrease in pH, and no color change occurred at pH 5. Isoelectric focusing. The possibility of some nonspecific reaction was excluded when clearly defined bands were observed on the isoelectric focusing plates (Fig. 1) . Serum There appeared to be a tendency to inverse correlation between the ability of a cephalosporin to inhibit the serum reaction and its stability to incubation with serum ( Tables 4  and 5 .
from several species. No relationship between 7-or 3-substituents and serum instability has so far been determined, apart from the highly conjugated 3-substituent in nitrocefin. Closely related compounds could behave very differently, and an unexpectedly wide range of stabilities was observed. The poor stability of 10485 to human serum was thought to be consistent with the very low recovery of total cephalosporin compound in the volunteers and also the reduction of its antibacterial activity in the presence of low concentrations of human serum. The possibility that nitrocefin was decomposed by bacterial ,B-lactamases was excluded by several properties such as its stability to heat, its failure to occur below pH 5.5, the pI of the species-specific bands, and its different inhibition spectrum. Cephalosporins and penicillins that inhibit bacterial,8-lactamases are stable to those enzymes (6), but there was an inverse correlation between serum stability and ability to inhibit the serum reaction. This was well illustrated by 10485, which was the least stable compound and the most effective inhibitor in human serum. In guinea pig serum, where it was much more stable, it was a much less effective inhibitor. It seems likely that the complex revealed in the albumin fraction by isoelectric focusing that However, some decomposition of nitrocefin continued in the presence of concentrations of 10485 that exceed the I50 concentration several hundred-fold, so that at least one component appears to be much more specific for nitrocefin. In addition, it also does not follow that the complex that can destroy some , 8-lactam com- pounds is responsible for the more commonly observed phenomenon of serum binding.
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